Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteaxiomed.com
CategoryMedical
Phone216.587.5566
Employees
Founded2001

Offices

Ohio Office
5350 Transportation Blvd
Suite 18
Garfield Heights, OH, 44125
USA
Pennsylvania Office
41 University Drive
Suite 400
Newtown, PA, 18940
USA

People

Chief Financial Officer
President & CEO & Board of Directors
Vice President for Clinical and Regulatory Affairs
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board Member
COO & Board of Directors

Funding

TOTAL $40.1M
FUNDING TOTAL $40.1M
Partial Close, 11/2009
$6.43M
Partial Close, 7/2010
$9.53M
Series D, 10/2010
Thomas, McNerney & Partners
CID Equity Capital
Early Stage Partners
Investor Growth Capital
MB Venture Capital Fund
Primus Capital
Reservoir Venture Partners
$15M
Grant, 3/2011
$500k
Series D, 5/2012
$5M
Series D, 1/2013
Investor Growth Capital
MB Venture Partners
Reservoir Venture Partners
Thomas, McNerney & Partners
Primus Capital
$3.6M

Tags

AxioMed Spine

AxioMed Spine Corporation, located in Cleveland, Ohio, was formed in 2001 to develop products with a goal of restoring spinal function to patients with degenerative spine disease; thus advancing the standard of care beyond fusion and first generation artificial discs. Since its inception, AxioMed has secured over $34M in private equity financing from prestigious venture capitalists. The company´s Freedom® Lumbar Disc has been developed and clinical trials initiated. The company is headed by CEO, Patrick McBrayer, who joined AxioMed in early 2006. Mr. McBrayer along with founder and COO, James Kuras, lead an experienced management and development team with significant history and expertise in spinal implants, including early artificial disc development efforts. Company employment includes professionals with extensive spine and engineering experience. The team is augmented by a Medical Advisory Panel of surgeons from leading spine centers and universities. The company´s headquarters include product development and testing, clinical and regulatory affairs, and manufacturing. AxioMed will leverage its background in lumbar disc replacement with an ongoing development project for the cervical spine.

Recent Milestones

Videos

Screenshots

Sources

  1. SEC (sec.gov) [edit]
  2. SEC (sec.gov) [edit]
  3. **OnBioVC Post 1,000** AxioMed Spine Corp.: Series D $15M (onbiovc.com) [edit]
  4. AxioMed Spine Further Funded by Ohio Loan–CORRECTED (pehub.com) [edit]
  5. AxioMed Spine Raises $5M in Series D Financing (finsmes.com) [edit]
  6. AxioMed Spine Raises $3.6M in Funding (finsmes.com) [edit]
Edit This Page
Last Edited 3/20/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy